Russell Frank Company’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | $823K | Buy |
3,992
+1,573
| +65% | +$324K | ﹤0.01% | 2259 |
|
|
2015
Q4 | $622K | Buy |
+2,419
| New | +$622K | ﹤0.01% | 2414 |
|
|
2015
Q3 | – | Sell |
-3,387
| Closed | -$636K | – | 3036 |
|
|
2015
Q2 | $636K | Buy |
3,387
+3,274
| +2,897% | +$615K | ﹤0.01% | 2503 |
|
|
2015
Q1 | $19K | Sell |
113
-7,826
| -99% | -$1.32M | ﹤0.01% | 2899 |
|
|
2014
Q4 | $1.83M | Buy |
7,939
+3,652
| +85% | +$841K | ﹤0.01% | 1845 |
|
|
2014
Q3 | $776K | Buy |
4,287
+900
| +27% | +$163K | ﹤0.01% | 2188 |
|
|
2014
Q2 | $545K | Buy |
+3,387
| New | +$545K | ﹤0.01% | 2299 |
|
|
2013
Q4 | – | Sell |
-2,302
| Closed | -$361K | – | 2954 |
|
|
2013
Q3 | $361K | Buy |
2,302
+667
| +41% | +$105K | ﹤0.01% | 2598 |
|
|
2013
Q2 | $283K | Buy |
+1,635
| New | +$283K | ﹤0.01% | 2487 |
|